Search Results

Now showing 1 - 2 of 2

Some of the metrics are blocked by your
consent settings
Signals for Muscular Protein Turnover and Insulin Resistance in Critically Ill Patients: A Narrative Review
(MDPI AG, 2023-02-21)
Sebastián P. Chapela
;
SIMANCAS RACINES, DANIEL ALEJANDRO
;
Martha Montalvan
;
Evelyn Frias-Toral
;
Alison Simancas-Racines
<jats:p>Sarcopenia in critically ill patients is a highly prevalent comorbidity. It is associated with a higher mortality rate, length of mechanical ventilation, and probability of being sent to a nursing home after the Intensive Care Unit (ICU). Despite the number of calories and proteins delivered, there is a complex network of signals of hormones and cytokines that affect muscle metabolism and its protein synthesis and breakdown in critically ill and chronic patients. To date, it is known that a higher number of proteins decreases mortality, but the exact amount needs to be clarified. This complex network of signals affects protein synthesis and breakdown. Some hormones regulate metabolism, such as insulin, insulin growth factor glucocorticoids, and growth hormone, whose secretion is affected by feeding states and inflammation. In addition, cytokines are involved, such as TNF-alpha and HIF-1. These hormones and cytokines have common pathways that activate muscle breakdown effectors, such as the ubiquitin–proteasome system, calpain, and caspase-3. These effectors are responsible for protein breakdown in muscles. Many trials have been conducted with hormones with different results but not with nutritional outcomes. This review examines the effect of hormones and cytokines on muscles. Knowing all the signals and pathways that affect protein synthesis and breakdown can be considered for future therapeutics.</jats:p>
Some of the metrics are blocked by your
consent settings
The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity
(MDPI AG, 2023-06-13)
ZAMBRANO ESPINOSA, ANA KARINA
;
CADENA ULLAURI, SANTIAGO ANDRE
;
Evelyn Frias-Toral
;
Sebastián Chapela
;
Martha Montalván
<jats:p>The very-low-calorie KD (VLCKD) is characterized by a caloric intake of under 800 kcal/day divided into less than 50 g/day of carbohydrate (13%) and 1 to 1.5 g of protein/kg of body weight (44%) and 43% of fat. This low carbohydrate intake changes the energy source from glucose to ketone bodies. Moreover, clinical trials have consistently shown a beneficial effect of VLCKD in several diseases, such as heart failure, schizophrenia, multiple sclerosis, Parkinson’s, and obesity, among others. The gut microbiota has been associated with the metabolic conditions of a person and is regulated by diet interactions; furthermore, it has been shown that the microbiota has a role in body weight homeostasis by regulating metabolism, appetite, and energy. Currently, there is increasing evidence of an association between gut microbiota dysbiosis and the pathophysiology of obesity. In addition, the molecular pathways, the role of metabolites, and how microbiota modulation could be beneficial remain unclear, and more research is needed. The objective of the present article is to contribute with an overview of the impact that VLCKD has on the intestinal microbiota composition of individuals with obesity through a literature review describing the latest research regarding the topic and highlighting which bacteria phyla are associated with obesity and VLCKD.</jats:p>

CRIS

Browse

Filters

Settings

Sort By

Results per page

Search Results